| scholarly article | Q13442814 |
| P50 | author | Leyi Wang | Q42411029 |
| P2093 | author name string | Ming Tan | |
| Ming Xia | |||
| Pengwei Huang | |||
| Xi Jiang | |||
| Weiming Zhong | |||
| Hao Fang | |||
| Monica M McNeal | |||
| P2860 | cites work | Presentation of heterologous peptides on plant viruses: genetics, structure, and function | Q46075765 |
| The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition | Q46111610 | ||
| E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. | Q54497752 | ||
| The formation of P particle increased immunogenicity of norovirus P protein | Q83274630 | ||
| Rapid evolution of pandemic noroviruses of the GII.4 lineage | Q21089614 | ||
| The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors | Q24563224 | ||
| Structural basis for the recognition of blood group trisaccharides by norovirus | Q24682901 | ||
| X-ray structure of glutathione S -transferase from the malarial parasite Plasmodium falciparum | Q27642569 | ||
| Structural Basis for the Receptor Binding Specificity of Norwalk Virus | Q27650214 | ||
| Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus–Host Interaction | Q27656916 | ||
| Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens | Q27671411 | ||
| A viral nanoparticle with dual function as an anthrax antitoxin and vaccine | Q28469319 | ||
| Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle | Q33341241 | ||
| Identification of cross-reactive norovirus CD4+ T cell epitopes | Q33614545 | ||
| Norovirus gastroenteritis, carbohydrate receptors, and animal models | Q33701801 | ||
| Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns | Q33788719 | ||
| The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors | Q34123964 | ||
| Molecular virology of hepatitis E virus | Q34166393 | ||
| Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production | Q34485266 | ||
| Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles | Q34724844 | ||
| C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. | Q35023707 | ||
| Norovirus-host interaction: multi-selections by human histo-blood group antigens | Q35146233 | ||
| Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period | Q35192903 | ||
| A candidate dual vaccine against influenza and noroviruses | Q35301295 | ||
| Structures of picorna-like plant viruses: implications and applications | Q35627066 | ||
| Noroviral P particle: structure, function and applications in virus-host interaction | Q36429481 | ||
| Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus | Q36445296 | ||
| Norovirus vaccine against experimental human Norwalk Virus illness | Q37144052 | ||
| Norwalk virus-like particles as vaccines | Q37706587 | ||
| Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns | Q38353300 | ||
| Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution | Q43664344 | ||
| A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula | Q45519794 | ||
| P433 | issue | 18 | |
| P304 | page(s) | 4480-4492 | |
| P577 | publication date | 2013-03-15 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Polyvalent complexes for vaccine development | |
| P478 | volume | 34 |
| Q37502688 | A dual vaccine candidate against norovirus and hepatitis E virus |
| Q36519453 | A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus |
| Q35152899 | Affinities of human histo-blood group antigens for norovirus capsid protein complexes |
| Q91576751 | Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform |
| Q34064413 | Branched-linear and agglomerate protein polymers as vaccine platforms |
| Q47547891 | Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model. |
| Q36914794 | Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus |
| Q104289416 | Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine |
| Q34160482 | Gangliosides are ligands for human noroviruses |
| Q30234848 | Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy |
| Q35008592 | Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay |
| Q92759295 | Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice |
| Q90231715 | Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development |
| Q36275589 | Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives |
| Q38819439 | Recent advancements in combination subunit vaccine development |
| Q27011503 | Recent advances in engineering polyvalent biological interactions |
| Q57154565 | Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q33678125 | The state of norovirus vaccines |
| Q26799737 | Tropical and travel-associated norovirus: current concepts |
| Q33578075 | Vaccine against norovirus |
| Q27004488 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae |
Search more.